The Kallikrein Gene 5 Splice Variant 2 Is a New Biomarker for Breast and Ovarian Cancer

References

Page 1

	Year	Citations
The I.M.A.G.E. Consortium: An Integrated Molecular Analysis of Genomes and Their Expression Greg Lennon, Charles Auffray, Mihael H. Polymeropoulos, Genomics EngineeringGeneticsMolecular BiologyMolecular GeneticsGenomics	1996	1.1K
The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease George M. Yousef Endocrine Reviews Molecular PhysiologyAutoimmune DiseaseDisease MechanismDisease EtiologyPathogenesis	2001	266
Purification, Molecular Cloning, and Expression of a Human Stratum Corneum Trypsin-like Serine Protease with Possible Function in Desquamation Maria Brattsand, Torbjörn Egelrud Journal of Biological Chemistry	1999	213
Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions Thangavel Alphonse Thanaraj Nucleic Acids Research	2001	179
New Nomenclature for the Human Tissue Kallikrein Gene Family Eleftherios P. Diamandis, George M. Yousef, Judith A. Clements, Clinical Chemistry	2000	179
Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer H Kim, Andreas Scorilas, Dionyssios Katsaros, British Journal of Cancer	2001	144
Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. George M. Yousef, Mary-Ellen Polymeris, Linda Grass, PubMed Breast OncologyImmunologyPathologyTumor BiologyOvarian Cancer	2003	133
Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers. Ying Dong, A. Kaushal, Maria Brattsand, PubMed	2003	111
The New Kallikrein-like Gene, KLK-L2 George M. Yousef, Eleftherios P. Diamandis Journal of Biological Chemistry	1999	98
Human Kallikrein Gene 5 (KLK5) Expression by Quantitative PCR: An Independent Indicator of Poor Prognosis in Breast Cancer George M. Yousef, Andreas Scorilas, Lianna Kyriakopoulou, Clinical Chemistry	2002	96

Page 1